Abstract
Controlled transscleral co-delivery of two drugs, edaravone (EDV) and unoprostone (UNO), using a platform that comprises a microfabricated reservoir, controlled-release cover, and drug formulations, which are made of photopolymerized poly(ethyleneglycol) dimethacrylates, shows synergistic retinal neuroprotection against light injury in rats when compared with single-drug-loaded devices. The device would offer a safer therapeutic method than intravitreal injections for retinal disease treatments.
Keywords:
edaravone; poly(ethyleneglycol) dimethacrylate; retina; transscleral drug delivery; unoprostone.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Administration, Ophthalmic
-
Animals
-
Antipyrine / administration & dosage
-
Antipyrine / analogs & derivatives
-
Antipyrine / pharmacokinetics
-
Dinoprost / administration & dosage
-
Dinoprost / analogs & derivatives
-
Dinoprost / pharmacokinetics
-
Drug Combinations
-
Drug Delivery Systems / instrumentation*
-
Drug Delivery Systems / methods*
-
Edaravone
-
Equipment Design
-
Methacrylates / chemistry
-
Neuroprotective Agents / administration & dosage
-
Neuroprotective Agents / pharmacokinetics
-
Polyethylene Glycols / chemistry
-
Polymethacrylic Acids / chemistry
-
Prostheses and Implants
-
Rats
-
Retina / metabolism*
-
Retina / radiation effects
-
Retinal Diseases / drug therapy*
-
Retinal Diseases / etiology
-
Retinal Diseases / metabolism
-
Retinal Diseases / prevention & control
-
Sclera / surgery
Substances
-
Drug Combinations
-
Methacrylates
-
Neuroprotective Agents
-
Polymethacrylic Acids
-
poly(ethylene glycol)-dimethacrylate
-
triethylene glycol dimethacrylate
-
Polyethylene Glycols
-
isopropyl unoprostone
-
Dinoprost
-
Edaravone
-
Antipyrine